-
Je něco špatně v tomto záznamu ?
Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies
T. Dillinger, R. Sheibani-Tezerji, W. Pulverer, I. Stelzer, MR. Hassler, J. Scheibelreiter, CU. Pérez Malla, M. Kuroll, S. Domazet, E. Redl, S. Ely, S. Brezina, A. Tiefenbacher, K. Rebhan, N. Hübner, B. Grubmüller, M. Mitterhauser, M. Hacker, A....
Jazyk angličtina Země Velká Británie
Typ dokumentu dopisy, práce podpořená grantem
NLK
BioMedCentral
od 2002-12-01
BioMedCentral Open Access
od 2002
Directory of Open Access Journals
od 2002
Free Medical Journals
od 2002
PubMed Central
od 2002
Europe PubMed Central
od 2002
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2002-01-01
Open Access Digital Library
od 2002-01-01
Open Access Digital Library
od 2002-07-01
Medline Complete (EBSCOhost)
od 2002-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2002
Springer Nature OA/Free Journals
od 2002-12-01
- MeSH
- epigeneze genetická MeSH
- epigenomika metody MeSH
- lidé MeSH
- management nemoci MeSH
- metylace DNA * MeSH
- náchylnost k nemoci MeSH
- nádorové biomarkery * MeSH
- nádory prostaty rezistentní na kastraci krev diagnóza genetika terapie MeSH
- prognóza MeSH
- stanovení celkové genové exprese MeSH
- tekutá biopsie * metody MeSH
- výpočetní biologie metody MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- dopisy MeSH
- práce podpořená grantem MeSH
Christian Doppler Laboratory for Applied Metabolomics Medical University of Vienna Vienna Austria
Comprehensive Cancer Center Medical University of Vienna Vienna Austria
Department of Clinical Pharmacology Medical University of Vienna Vienna Austria
Department of Health Economics Center for Public Health Medical University of Vienna Vienna Austria
Department of Pathology Medical University of Vienna Vienna Austria
Department of Urology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Urology Medical University Vienna Vienna Austria
Department of Urology University of Texas Southwestern Medical Center Dallas TX USA
Department of Urology Weill Cornell Medical College New York NY USA
European Association of Urology Research Foundation Arnhem The Netherlands
Institute of Cancer Research Department of Medicine 1 Medical University of Vienna Vienna Austria
Karl Landsteiner Institute of Urology and Andrology Vienna Austria
Ludwig Boltzmann Institute Applied Diagnostics Vienna Austria
Unit of Laboratory Animal Pathology University of Veterinary Medicine Vienna Austria
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011405
- 003
- CZ-PrNML
- 005
- 20220506130423.0
- 007
- ta
- 008
- 220425s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12943-021-01445-0 $2 doi
- 035 __
- $a (PubMed)34980142
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Dillinger, Thomas $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria $u Department of Pathology, Medical University of Vienna, Vienna, Austria
- 245 10
- $a Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies / $c T. Dillinger, R. Sheibani-Tezerji, W. Pulverer, I. Stelzer, MR. Hassler, J. Scheibelreiter, CU. Pérez Malla, M. Kuroll, S. Domazet, E. Redl, S. Ely, S. Brezina, A. Tiefenbacher, K. Rebhan, N. Hübner, B. Grubmüller, M. Mitterhauser, M. Hacker, A. Weinhaeusel, J. Simon, M. Zeitlinger, A. Gsur, G. Kramer, SF. Shariat, L. Kenner, G. Egger
- 650 12
- $a nádorové biomarkery $7 D014408
- 650 _2
- $a výpočetní biologie $x metody $7 D019295
- 650 12
- $a metylace DNA $7 D019175
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a náchylnost k nemoci $7 D004198
- 650 _2
- $a epigeneze genetická $7 D044127
- 650 _2
- $a epigenomika $x metody $7 D057890
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a tekutá biopsie $x metody $7 D000073890
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a nádory prostaty rezistentní na kastraci $x krev $x diagnóza $x genetika $x terapie $7 D064129
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sheibani-Tezerji, Raheleh $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria $u Department of Pathology, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/000000021025646X
- 700 1_
- $a Pulverer, Walter $u Health & Environment Department, Molecular Diagnostics, AIT-Austrian Institute of Technology GmbH, Vienna, Austria
- 700 1_
- $a Stelzer, Ines $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria $u Department of Health Economics, Center for Public Health, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Hassler, Melanie R $u Department of Pathology, Medical University of Vienna, Vienna, Austria $u Department of Urology, Medical University Vienna, Vienna, Austria
- 700 1_
- $a Scheibelreiter, Janine $u Department of Pathology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Pérez Malla, Carlos Uziel $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
- 700 1_
- $a Kuroll, Madeleine $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
- 700 1_
- $a Domazet, Sandra $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
- 700 1_
- $a Redl, Elisa $u Department of Pathology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Ely, Sarah $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria $u Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Brezina, Stefanie $u Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Tiefenbacher, Andreas $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria $u Department of Pathology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Rebhan, Katharina $u Department of Urology, Medical University Vienna, Vienna, Austria
- 700 1_
- $a Hübner, Nicolai $u Department of Urology, Medical University Vienna, Vienna, Austria
- 700 1_
- $a Grubmüller, Bernhard $u Department of Urology, Medical University Vienna, Vienna, Austria $1 https://orcid.org/0000000287461488
- 700 1_
- $a Mitterhauser, Markus $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria $u Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Vienna, Austria $1 https://orcid.org/0000000331735272
- 700 1_
- $a Hacker, Marcus $u Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Vienna, Austria $1 https://orcid.org/0000000242224083
- 700 1_
- $a Weinhaeusel, Andreas $u Health & Environment Department, Molecular Diagnostics, AIT-Austrian Institute of Technology GmbH, Vienna, Austria $1 https://orcid.org/0000000293181204
- 700 1_
- $a Simon, Judit $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria $u Department of Health Economics, Center for Public Health, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000192798627
- 700 1_
- $a Zeitlinger, Markus $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria $u Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000218733953
- 700 1_
- $a Gsur, Andrea $u Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000297951528
- 700 1_
- $a Kramer, Gero $u Department of Urology, Medical University Vienna, Vienna, Austria
- 700 1_
- $a Shariat, Shahrokh F $u Department of Urology, Medical University Vienna, Vienna, Austria $u Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA $u Department of Urology, Weill Cornell Medical College, New York, NY, USA $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria $u Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan $u European Association of Urology Research Foundation, Arnhem, The Netherlands $1 https://orcid.org/0000000266276179
- 700 1_
- $a Kenner, Lukas $u Department of Pathology, Medical University of Vienna, Vienna, Austria $u Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Unit of Laboratory Animal Pathology, University of Veterinary Medicine, Vienna, Austria $u Christian Doppler Laboratory for Applied Metabolomics, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000321841338
- 700 1_
- $a Egger, Gerda $u Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria. gerda.egger@meduniwien.ac.at $u Department of Pathology, Medical University of Vienna, Vienna, Austria. gerda.egger@meduniwien.ac.at $u Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. gerda.egger@meduniwien.ac.at $1 https://orcid.org/000000032489155X
- 773 0_
- $w MED00008245 $t Molecular cancer $x 1476-4598 $g Roč. 21, č. 1 (2022), s. 7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34980142 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130415 $b ABA008
- 999 __
- $a ok $b bmc $g 1789141 $s 1162603
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 21 $c 1 $d 7 $e 20220103 $i 1476-4598 $m Molecular cancer $n Mol Cancer $x MED00008245
- LZP __
- $a Pubmed-20220425